Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients
Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...
المؤلفون الرئيسيون: | Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Elsevier
2023-12-01
|
سلاسل: | Translational Oncology |
الموضوعات: | |
الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S1936523323001857 |
مواد مشابهة
-
Complete response in a patient with BRAF-mutant metastatic melanoma achieved with the multidisciplinary approach: a case report
حسب: Hana Garaj, وآخرون
منشور في: (2024-01-01) -
Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
حسب: Senar Ebinç, وآخرون
منشور في: (2023-09-01) -
A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
حسب: Wu L, وآخرون
منشور في: (2021-02-01) -
Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
حسب: Katarina Mirjačić Martinović, وآخرون
منشور في: (2023-04-01) -
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
حسب: Dugan MM, وآخرون
منشور في: (2024-07-01)